Comparison of therapeutic and immunosuppressive effects of azathioprine, prednisolone and combined therapy in NZP-NZW mice.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D000917:Antibody Formation; D000942:Antigens, Bacterial; D001323:Autoantibodies; D001379:Azathioprine / Q000008:administration & dosage* / Q000627:therapeutic use; D003298:Coombs Test; D004247:DNA; D004195:Disease Models, Animal; D004357:Drug Synergism; D005260:Female; D007165:Immunosuppression Therapy; D007668:Kidney / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D051379:Mice; D009393:Nephritis / Q000276:immunology / Q000401:mortality; D011135:Polysaccharides, Bacterial / Q000032:analysis; D011239:Prednisolone / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors; D005719:gamma-Globulins / Q000032:analysis
D000888:Antibodies, Anti-Idiotypic; D000974:Antibodies, Antinuclear; D000942:Antigens, Bacterial; D001323:Autoantibodies; D011135:Polysaccharides, Bacterial; D005719:gamma-Globulins; D004247:DNA; D011239:Prednisolone; D001379:Azathioprine